Literature DB >> 24797118

Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.

Kai Hübel1, Javier de la Rubia, Nabih Azar, Paolo Corradini.   

Abstract

The use of autologous haematopoietic stem cell transplantation (ASCT) has increased considerably in lymphoid malignancies in the last decade, and it is now considered as the standard of care in particular circumstances. This review aims to present an overview of the current situation with ASCT in lymphoid malignancies in Europe, in terms of both current use and issues. It will also look briefly at ASCT in rarer haematological malignancies and at the future. It is intended as a reflection of opinion from selected centres in Europe and as an aid to understanding for those who are new to the area. The review is based on a series of four preceptorship meetings held in Europe in 2013.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autologous haematopoietic stem cell transplantation; lymphoma; mobilisation; myeloma

Mesh：

Year:  2014        PMID： 24797118     DOI： 10.1111/ejh.12362

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


  7 in total

1.  Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade's experience from Lebanon.

Authors:  Rima Moghnieh; Dania Abdallah; Lyn Awad; Tamima Jisr; Anas Mugharbil; Ali Youssef; Hani Tamim; Samer Khaldieh; Oula Massri; Najat Rashini; Youssef Hamdan; Ahmad Ibrahim
Journal:  Infection       Date:  2018-08-24       Impact factor: 3.553

2.  A retrospective study of autologous stem cell mobilization by G-CSF in combination with chemotherapy in patients with multiple myeloma and lymphoma.

Authors:  Gaofeng Zheng; Jingsong He; Zhen Cai; Donghua He; Yi Luo; Jimin Shi; Guoqing Wei; Jie Sun; Weiyan Zheng
Journal:  Oncol Lett       Date:  2019-12-03       Impact factor: 2.967

3.  Cryostorage to What End? - Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients.

Authors:  Katharina Kriegsmann; Petra Pavel; Tilmann Bochtler; Anita Schmitt; Sandra Sauer; Mark Kriegsmann; Thomas Bruckner; Stefan Klein; Harald Klüter; Carsten Müller-Tidow; Patrick Wuchter
Journal:  Transfus Med Hemother       Date:  2020-09-15       Impact factor: 3.747

4.  High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.

Authors:  Katharina Lisenko; Sandra Sauer; Thomas Bruckner; Gerlinde Egerer; Hartmut Goldschmidt; Jens Hillengass; Johann W Schmier; Sofia Shah; Mathias Witzens-Harig; Anthony D Ho; Patrick Wuchter
Journal:  BMC Cancer       Date:  2017-02-22       Impact factor: 4.430

5.  Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin, and non-Hodgkin lymphoma: the first experience from Palestine.

Authors:  Riad Amer; Husam Salameh; Sultan Mosleh; Adham Abu-Taha; Hamza Hamayel; Ahmad Enaya; Amro Adas; Ahmad Khursani; Mohamad Wild-Ali; Taghreed Mousa; Maher Battat; Aiman Daifallah; Amer Koni; Ramzi Shawahna
Journal:  BMC Infect Dis       Date:  2022-09-07       Impact factor: 3.667

6.  Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.

Authors:  Sandra Sauer; Petra Pavel; Anita Schmitt; Martin Cremer; Mark Kriegsmann; Thomas Bruckner; Karin Jordan; Patrick Wuchter; Carsten Müller-Tidow; Katharina Kriegsmann
Journal:  BMC Cancer       Date:  2020-04-25       Impact factor: 4.430

7.  Early infection in post-autologous hematopoietic stem cell transplant patients: Princess Noorah Oncology Center experience.

Authors:  Roaa S Gassas; Ahmed N Absi; Abdulrahman A Alghamdi; Ahmed S Alsaeed; Sameer M Alamoudi; Ihab Y Hemaidi; Majed D Alahmadi; Walaa A Rajkhan; Mannar M Khalil; Saleem K Dadah; Ahmed S Higazi; Amani S Ahmed
Journal:  Saudi Med J       Date:  2021-08       Impact factor: 1.422
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.